You Searched For "Oxford Covid 19 vaccine" and got 20 results
Sort By:
1 min read
Oxford COVID-19 vaccine India approval likely to be considered today
The Subject Expert Committee of the Central Drug Standard Control Organization (CDSCO) is set to me…
2 mins read
Here's what you need to know about Oxford Covid-19 vaccine
New Delhi, Jan 1 (IANS) With the UK giving the green light to the Covid-19 vaccine developed by Oxf…
3 mins read
PM Modi warns against complacency before COVID-19 vaccine — asks states to begin work on cold storage facilities
The mistakes made ahead of the festive season is what led to the surge of COVID-19 cases in India, …
1 min read
Australia begins production of Oxford-developed Covid-19 vaccine
Despite still undergoing clinical trials, the vaccine, which was co-developed by pharmaceutical …
3 mins read
Phase II trial of Oxford Covid-19 vaccine candidate to begin in PGI Chandigarh
New Delhi, Aug 27 (IANS) The Post Graduate Institute of Medical Education and Research (PGIMER) in …
2 mins read
Oxford COVID-19 vaccine safe for people with weak immunity says Oxford Professor Sarah Gilbert
Volunteers have begun participating in Brazil's first clinical trial of Oxford COVID-19 vaccine. …
2 mins read
DCGI gives nod to Serum Institute of India for phase 2 and 3 human clinical trials of the Oxford COVID-19 vaccine candidate
"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the C…
PTI
3 mins read
The Oxford COVID-19 vaccine is 'progressing very well,' according to the lead scientists, who said 10,000 more people will be inoculated
Researchers at Oxford University said Friday that they would move on to the next phase of testing, …
Bill Bostock
5 mins read
From new variant IHU to utility of booster doses — these are five lessons India can learn from the third wave of COVID-19 in other countries
There are at least 5 learnings emerging from different countries facing the third wave of COVID-19 …
1 min read
AstraZeneca vaccine is still on WHO's radar
The World Health Organization (WHO) said that it was still conducting its safety review of the Astr…
3 mins read
There's no evidence yet that AstraZeneca's vaccine causes blood clots, and experts say any risks are outweighed by the shot's benefits
Denmark and Norway both suspended the roll out of AstraZeneca's COVID-19 vaccine, but many experts …
Dr. Catherine Schuster-Bruce
3 mins read
Three month gap between Oxford vaccine jabs results in better efficacy, says study
"Vaccine supply is likely to be limited, at least in the short term, and so policy-makers mu…
PTI
2 mins read
Haven, the Amazon-Berkshire Hathaway-JPMorgan health venture, is disbanding
These are Business Insider's biggest healthcare stories for January 5.
Lydia Ramsey Pflanzer
2 mins read
India will soon begin world's biggest COVID-19 vaccination programme: PM Modi
Lauding the scientists and technicians for the 'Made in India' vaccines, he said the country is…
PTI
4 mins read
Serum’s Covishield vaccine gets expert panel recommendation, paving the way for first authorized COVID-19 shot in India
An expert panel of India's drug regulator on Friday recommended emergency use approval for Oxford-A…
2 mins read
The world is relying on a UK drugmaker with limited experience in crafting vaccines to help fight the pandemic, and AstraZeneca's stumbles are delaying its response
The US bought 300 million doses of AstraZeneca's vaccine for $1.2 billion, despite the fact the fir…
Allana Akhtar
1 min read
COVID-19 vaccine in India: Expert panel to review Pfizer, Serum and Bharat Biotech's emergency use application tomorrow
The Indian arm of US pharmaceutical giant Pfizer had on December 4 sought approval for its va…
PTI
1 min read
Bharat Biotech applies for emergency use approval for its COVID-19 vaccine Covaxin
Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Coun…
PTI
2 mins read
Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India
"Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use au…
PTI
4 mins read
COVID-19 vaccine will be priced at ₹1,000 and would be available by February for healthcare workers and elderly people, says Serum CEO Adar Poonawalla
"It will probably take two or three years for every Indian to get inoculated, not just because o…